Pilloxa Collaborates with Sandoz Nordics to Improve Medication Adherence

Pilloxa Sandoz partnership
Pilloxa's smart pillbox (Image: Pilloxa)

Swedish digital startup Pilloxa announced it will collaborate with Novartis division Sandoz Nordics to improve medication adherence for transplanted patients.

The initial phase aims to support Swedish transplant clinics with Pilloxa’s innovative smart pillbox in order to facilitate improved medication adherence by transplanted patients. The smart pillbox is connected to an app and a cloud solution, along with data driven services, that aims to help patients take their medication on time.

Read more cue-Rx Medication Adherence System to Deliver Prescription in their Original Containers

Patients receiving transplants must adhere to their medications optimally. To keep their organs functioning properly they must follow lifelong daily medication, and a few missed doses can result in organ rejection.

The built-in sensors in the pillbox detect when patients take their medication. There are 14 compartments in the pillbox, which is connected to the patients’ mobile phones. An LED lights up telling patients when its time to take their medicine.

If the patient forgets to take their medication, they receive a notification. The app also includes a medicines list, a dashboard giving information about their medication history, and a so-called “motivational tool,” reports MobiHealthNews.

Founded in 2015, Pilloxa originates from the Karolinska Institute, Stockholm County Council and the Swedish Royal Institute for Technology.

The startup recently raised money from Swedish angel investors and was awarded funding from the Swedish innovation agency Vinnova and EIT Health. In March, the company announced a strategic partnership with Bayer AG.

Patient holding medicines on his palm
Image: Creative commons

Read more Non-adherence to medications can lead to negative healthcare outcomes: Interview with Shark Dreams CEO Dharma Teja Nukarapu

“Pilloxa strives to be at the forefront of a new paradigm within personalized healthcare.  We are happy to partner with Sandoz to tackle the problem of inadequate adherence to medication and we strongly believe that this will increase quality of life for transplanted patients,” said Francesco Mazzotta, CEO Pilloxa.

“Together Sandoz and Pilloxa go beyond the pill and aim to empower the patients to improve their own outcomes.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Previous articleMAY 2019
Next articleGoogle and Qualcomm Launch Dev Kit for Google Assistant Headphones
Sam Draper
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)wearable-technologies.com.